Old Web
English
Sign In
Acemap
>
Paper
>
Off-Label Use Of Rituximab For Systemic Lupus Erythematosus in Europe: Limited Use Mostly In Refractory Patients
Off-Label Use Of Rituximab For Systemic Lupus Erythematosus in Europe: Limited Use Mostly In Refractory Patients
2013
R. van Vollenhoven
M. Mild
Alessandro Doria
T. Doerner
G. Ferraccioli
F. Houssiau
T. W. J. Huizinga
Da Isenberg
László Kovács
Guillermo Ruiz-Irastorza
Danilo Squatrito
A E Voskuyl
Marta Mosca
Gd Sebastiani
Murat Inanc
G Szuecs
Søren Jacobsen
A. Castro
Keywords:
Rituximab
Off-label use
Immunology
Lupus erythematosus
Rheumatology
Internal medicine
Medicine
Refractory
systemic lupus
Dermatology
Correction
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]